Pharmaron Beijing Co Ltd (300759) — Cash Flow-to-Debt Ratio
Pharmaron Beijing Co Ltd (300759) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥1.04 Billion could theoretically repay 0% of its total liabilities (CN¥10.62 Billion) in one year. See how financially flexible is Pharmaron Beijing Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharmaron Beijing Co Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Pharmaron Beijing Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Pharmaron Beijing Co Ltd.
Annual Cash Flow-to-Debt Ratio for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year debt coverage analysis for Pharmaron Beijing Co Ltd. Check how high is Pharmaron Beijing Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥2.58 Billion | CN¥9.70 Billion | ▲ +27.7% |
| 2023 | 0.21x | CN¥2.75 Billion | CN¥13.24 Billion | ▼ -6.3% |
| 2022 | 0.22x | CN¥2.14 Billion | CN¥9.65 Billion | ▼ -12.7% |
| 2021 | 0.25x | CN¥2.06 Billion | CN¥8.09 Billion | ▼ -54.1% |
| 2020 | 0.55x | CN¥1.65 Billion | CN¥2.98 Billion | ▲ +23.8% |
| 2019 | 0.45x | CN¥938.59 Million | CN¥2.10 Billion | ▲ +38.6% |
| 2018 | 0.32x | CN¥737.26 Million | CN¥2.28 Billion | ▲ +11.6% |
| 2017 | 0.29x | CN¥552.22 Million | CN¥1.91 Billion | ▲ +27.7% |
| 2016 | 0.23x | CN¥235.77 Million | CN¥1.04 Billion | ▲ +5.0% |
| 2015 | 0.22x | CN¥216.94 Million | CN¥1.01 Billion | ▲ +1096.2% |
| 2014 | 0.02x | CN¥12.13 Million | CN¥673.22 Million | — |